Text this: Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC Patients treated with first-line intercalated erlotinib and chemotherapy

 _    _      ___     __   __   _    _    _    _   
| |  | ||   / _ \\   \ \\/ // | || | || | |  | || 
| |/\| ||  | / \ ||   \   //  | || | || | |/\| || 
|  /\  ||  | \_/ ||   / . \\  | \\_/ || |  /\  || 
|_// \_||   \___//   /_//\_\\  \____//  |_// \_|| 
`-`   `-`   `---`    `-`  --`   `---`   `-`   `-`